FibroGen (FGEN) Appoints Michael Kauffman to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to FibroGen (FGEN) Appoints Michael Kauffman to its Board

FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Directors

June 9, 2025 4:02 PM EDT

SAN FRANCISCO, June 09, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the appointment of Dr. Michael Kauffman to its Board of Directors effective June 4, 2025.

Michael is a well-recognized biotech industry veteran, who brings a wealth of biotech leadership experience to our board, said James Schoeneck, chairman of the board of directors of FibroGen. His expertise spanning all stages of drug development will be invaluable as FibroGen progresses its pipeline. Michaels deep understanding of oncology will help the company through anticipated near-term clinical milestones and potential value-drivers.

FibroGen has differentiated potential... More